Companies · Healthtech
CHICAGO · Healthtech · refined from filed group “Other Health Care”
Diligence memoA one-page analyst read on Health Intelligence Co Llc — recommendation, valuation, rhythm, risks.→Health Intelligence Co Llc has raised $71M over 2 rounds; too few niche peers to rank its valuation yet.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Health Intelligence Co Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Health Intelligence Co Llc is one of 2138 Healthtech companies tracked from CHICAGO. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.
Round size and date are reported; the stage label is inferred from round size (latest is Series C — a $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.
Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 94% of sector peers (real $). Modeled value above 97% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $28.0M | 2010-12-17 | $155.6M | $694.1M | 85% |
| Series C | $42.6M | 2012-04-05 | $283.7M | $1.1B | 90% |
| Series C | $42.6M | 2012-04-05 | $283.7M | $1.1B | 85% |
| Series C | $42.6M | 2012-04-05 | $283.7M | $1.1B | 85% |
| Series A | $9.4M | 2012-04-05 | $42.7M | $212.0M | 85% |
| Series B | $34.5M | 2012-04-05 | $191.9M | $856.0M | 85% |
| Series C | $42.6M | 2012-04-05 | $283.7M | $1.1B | 85% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| SWATI ABBOTT | — | 2 other | 2012-04 |
| DOUG PORTER | — | 1 other | 2010-12 |
| ROGER WILSON | — | 1 other | 2010-12 |
| SCOTT SEROTA | — | 1 other | 2012-04 |
| STEVEN MARTIN | — | 1 other | 2012-04 |
| ALLEN D. MALTZ | — | — | 2012-04 |
| ALLEN R. MALTZ | — | — | 2012-04 |
| ARNOLD DUKE LIVERMORE II | — | — | 2010-12 |
| BOB KOLODGY | — | — | 2010-12 |
| BRIAN DUKE HEDBERG | — | — | 2010-12 |
| BRIAN HEDBERG | — | — | 2012-04 |
| BRIAN R. HEDBERG | — | — | 2012-04 |
| BRIAN S. HEDBERG | — | — | 2012-04 |
| CHARLES ALLISON | — | — | 2012-04 |
| DARREN H. ROGERS | — | — | 2012-04 |
| DARREN RODGERS | — | — | 2012-04 |
| DAVID H. KING | — | — | 2012-04 |
| DEBORAH D. RICE-JOHNSON | — | — | 2012-04 |
| DONALD R. FISCHER | — | — | 2012-04 |
| DONALD R. FISCHER, M.D. | — | — | 2010-12 |
| DR. THOMAS MARK HAWKINS | — | — | 2010-12 |
| Garret Hargrave | — | — | 2012-04 |
| JACQUELINE H. STUDER | — | — | 2012-04 |
| JAMES D. BAILEY | — | — | 2012-04 |
Health Intelligence Co Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Prognos Health Inc. | Healthtech | Series B | $63.4M | $235.2M | network1 shared operator · same sector |
| Stellar Health Group, Inc. | Healthtech | Series C | $71.1M | $1.1B | same sector · same stage |
| Fresenius Medical Care Voorhees, LLC | Healthtech | Series C | $71.1M | $1.8B | same sector · same stage |
| Brightside Health, Inc. | Healthtech | Series C | $69.9M | $800.8M | same sector · same stage |
| Ophelia Health, Inc. | Healthtech | Series C | $68.4M | $859.9M | same sector · same stage |
| Diverge Health, Inc. | Healthtech | Series C | $68.2M | $407.8M | same sector · same stage |
| Eden Health, Inc. | Healthtech | Series C | $73.4M | $1.3B | same sector · same stage |
| Clarify Medical, Inc. | Healthtech | Series C | $67.6M | $776.1M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Healtheo360 LLC | Healthtech | Seed | $6.7M | 88% |
| Intelicare Health Services, Llc | Healthtech | Seed | $25.0M | 88% |
| WELL Health Technologies Corp. | Healthtech | Seed | $92.8M | 88% |
| Innovative Health Llc | Healthtech | Series A | $112.9M | 87% |
| Medical Monitoring Holdings, LLC | Healthtech | Series A | $17.6M | 87% |
| What About Health, Inc. | Healthtech | Pre-Seed | $7.6M | 87% |
| HealthEC, LLC | Healthtech | Series A | $33.3M | 87% |
| Health Care Solutions Inc. | Healthtech | Seed | $26.8M | 87% |
See where Health Intelligence Co Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Health Intelligence Co Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.